Targeting the Oligomerization of BCR/ABL by Membrane Permeable Competitive Peptides Inhibits the Proliferation of Philadelphia Chromosome Positive Leukemic Cells
dc.contributor.author | Mian, Afsar Ali | |
dc.contributor.author | Schull, Marion | |
dc.contributor.author | Oancea, Claudia | |
dc.contributor.author | Najajreh, Yousef | |
dc.contributor.author | Mahajna, Jamal | |
dc.contributor.author | Goldblum, Amiram | |
dc.contributor.author | Ottmann, Oliver Gerhard | |
dc.contributor.author | Beissert, Tim | |
dc.date.accessioned | 2018-09-15T11:43:01Z | |
dc.date.available | 2018-09-15T11:43:01Z | |
dc.date.issued | 2011-12-30 | |
dc.description.abstract | The BCR/ABL fusion protein is the hallmark of Philadelphia Chromosome positive (Ph+) leukemia. The constitutive activation of the ABL-kinase in BCR/ABL cells induces the leukemic phenotype. Targeted inhibition of BCR/ABL by small molecule inhibitors reverses the transformation potential of BCR/ABL. Recently, we definitively proved that targeting the tetramerization of BCR/ABL mediated by the N-terminal coiled-coil domain (CC) using competitive peptides, representing the helix-2 of the CC, represents a valid therapeutic approach for treating Ph+ leukemia. To further develop competitive peptides for targeting BCR/ABL, we created a membrane permeable helix-2 peptide (MPH-2) by fusing the helix-2 peptide with a peptide transduction tag. In this study, we report that the MPH-2: (i) interacted with BCR/ABL in vivo; (ii) efficiently inhibited the autophosphorylation of BCR/ABL; (iii) suppressed the growth and viability of Ph+ leukemic cells; and (iv) was efficiently transduced into mononuclear cells (MNC) in an in vivo mouse model. | en_US |
dc.description.sponsorship | This project was supported by a grant from the Deutsche Forschungsgemeinschaft to M.R., Y.N., J.M., and A.G. (DFG-RU 728/3-2). M.R. is further funded by grants from Deutsche Krebshilfe e.V. (DKH-107063 and DKH-107741), Deutsche José Carreras Leukämie-Stiftung e.V. (DJCLS - R 07/27f), and the Alfred und Angelika Gutermuth Foundation. | en_US |
dc.identifier.issn | 1874-2769 | |
dc.identifier.uri | https://dspace.alquds.edu/handle/20.500.12213/902 | |
dc.language.iso | en_US | en_US |
dc.publisher | Bentham Science Publishers | en_US |
dc.subject | Philadelphia Chromosome-positive leukemia | en_US |
dc.subject | BCR/ABL | en_US |
dc.subject | molecular targeting | en_US |
dc.subject | competitive peptide | en_US |
dc.subject | oligomerization | en_US |
dc.title | Targeting the Oligomerization of BCR/ABL by Membrane Permeable Competitive Peptides Inhibits the Proliferation of Philadelphia Chromosome Positive Leukemic Cells | en_US |
dc.type | Article | en_US |